GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (CHIX:HIKl) » Definitions » Cyclically Adjusted PB Ratio

Hikma Pharmaceuticals (CHIX:HIKL) Cyclically Adjusted PB Ratio : 2.59 (As of Dec. 14, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-12-14), Hikma Pharmaceuticals's current share price is £19.26. Hikma Pharmaceuticals's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was £7.44. Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 2.59.

The historical rank and industry rank for Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

CHIX:HIKl' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.05   Med: 4.33   Max: 10.44
Current: 2.58

During the past 13 years, Hikma Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 10.44. The lowest was 2.05. And the median was 4.33.

CHIX:HIKl's Cyclically Adjusted PB Ratio is ranked worse than
54.5% of 655 companies
in the Drug Manufacturers industry
Industry Median: 2.21 vs CHIX:HIKl: 2.58

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hikma Pharmaceuticals's adjusted book value per share data of for the fiscal year that ended in Dec23 was £7.854. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is £7.44 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hikma Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Hikma Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.26 4.93 3.80 2.27 2.38

Hikma Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 - 2.27 - 2.38

Competitive Comparison of Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Hikma Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=19.26/7.44
=2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hikma Pharmaceuticals's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Hikma Pharmaceuticals's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=7.854/130.5000*130.5000
=7.854

Current CPI (Dec23) = 130.5000.

Hikma Pharmaceuticals Annual Data

Book Value per Share CPI Adj_Book
201412 3.844 99.900 5.021
201512 4.466 100.400 5.805
201612 7.998 102.200 10.213
201712 4.693 105.000 5.833
201812 5.513 107.100 6.718
201912 6.666 108.500 8.018
202012 6.891 109.400 8.220
202112 7.968 114.700 9.066
202212 7.959 125.300 8.289
202312 7.854 130.500 7.854

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hikma Pharmaceuticals  (CHIX:HIKl) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hikma Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hikma Pharmaceuticals Business Description

Traded in Other Exchanges
Address
1 New Burlington Place, London, GBR, W1S 2HR
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

Hikma Pharmaceuticals Headlines

No Headlines